Description
Inhalipt Pharmacodynamics
Soluble sulfanilamide, sodium sulfathiazole, eucalyptus oil
Combined drug for topical use in infectious and inflammatory diseases of the mouth and throat. Soluble sulfonamides included in the drug have antimicrobial action (against Gram-positive and Gram-negative bacteria causing diseases of the mouth and throat). Timol, eucalyptus oil and peppermint oil have antifungal (against fungi of the genus Candida), antimicrobial, anti-inflammatory and mild analgesic effect.
Indications
Tonsillitis, pharyngitis, laryngitis, aphthous stomatitis.
Contraindications .
Hypersensitivity to the drug components, pregnancy, breast-feeding, children under 3 years of age.
Use during pregnancy and lactation
The use of Ingalipt is contraindicated in pregnancy and during breast-feeding. The drug contains sulfonamides which are able to penetrate through the placenta when applied topically and are detected in the fetal blood. Development of teratogenic action is possible. If it is necessary to use the drug during lactation, breast-feeding should be stopped; it penetrates into breast milk and may cause nuclear jaundice in newborns.
Directions for use and dosages
- It is applied topically. After removing the safety cap from the balloon, spray a suspension into the oral cavity for 1-2 seconds.
- Irrigation is carried out 3-4 times a day with prior mouthwash with boiled water.
